Increased ErbB2 Signaling Is an Early Adaptation to Androgen Signaling Inhibition and Persists in Castration-Resistant Prostate Cancer.

Saved in:
Bibliographic Details
Title: Increased ErbB2 Signaling Is an Early Adaptation to Androgen Signaling Inhibition and Persists in Castration-Resistant Prostate Cancer.
Authors: Owiredu J; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Ersoy-Fazlioglu B; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Poluben L; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Calagua C; Department of Pathology, Mount Sinai, New York, New York., Dennehy C; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Stavridi AM; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Wang L; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Voznesensky O; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Xie F; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Ye H; Department of Pathology, Cedars Sinai Medical Center, Los Angeles, California., Sun Y; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Einstein DJ; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Gao X; Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts., Mantia C; Division of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Taplin ME; Division of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Muller WJ; Goodman Cancer Research Centre, McGill University, Montreal, Canada., Balk SP; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Russo JW; Division of Medical Oncology and Cancer Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Nov 03; Vol. 31 (21), pp. 4598-4610.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-22-3683